Search Results

Gencurix Obtains Approval for Companion Diagnostic of Digital PCR-based EGFR Mutation Test

Gencurix, a leading cancer molecular diagnostics company, has obtained approval from the Korean Ministry of Food and Drug Safety for its Droplex EGFR Mutation Test v2.

June 13, 2023

·

2 min read

Gencurix Announces Clinical Research Results At ASCO 2023 Demonstrating Outstanding Performance of GenesWell BCT, the Company’s Breast Cancer Prognostic Test, Compared to Global Best-Selling Test, OncotypeDX

Gencurix, a leading provider of cancer molecular diagnostics, announced the release of clinical research results directly comparing the accuracy of its breast cancer prognostic test, GenesWell BCT, with Oncotype DX, the globally top-selling test, confirming its outstanding performance.

June 5, 2023

·

4 min read

FDA

Gencurix wins FDA EUA for COVID-19 Test Kit

A Korean molecular diagnostic company, Gencurix, Inc., has announced that they have received U.S. Food and Drug Administration (FDA)'s Emergency Use Authorization (EUA) for its GenePro SARS-CoV-2 Test.

June 24, 2020

·

2 min read

Gencurix Publishes Companion Diagnostics Technology with Reflection of Quality of Nucleic Acid Samples in International Journal

Gencurix announced that the nucleic acid quality index (iQC index), allowing the measurement of the quality of the nucleic acid in molecular diagnosis is published in the Journal of Scientific Reports on Jan 2.

January 11, 2018

·

6 min read

Gencurix Publishes A Clinical Validation Study On GenesWell BCT, A New Breast Cancer Prognostic Test

March 28, 2017

·

4 min read

New publication shows different result of risk classification between GenesWell BCT and Oncotype DX in breast cancer patients 50 years old or younger.

Gencurix, Inc., a company dedicated in development and market of innovative molecular diagnostics, announced the publication of a new study onFrontiers in Oncology comparing GenesWell™ BCT, a prognostic multigene test, with Genomic Health’s Oncotype DX in patients with early-stage breast cancer

August 6, 2019

·

5 min read